Cutting edge: GPR35/CXCR8 is the receptor of the mucosal chemokine CXCL17

Journal of Immunology

Volumn 194, Issue 1, 2015, Pages 29-33

  Maravillas Montero, Jose L ^a,c   Burkhardt, Amanda M ^a   Hevezi, Peter A ^a   Carnevale, Christina D ^a   Smit, Martine J ^a,b   Zlotnik, Albert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CXC8 CHEMOKINE; CXCL17 CHEMOKINE; G PROTEIN COUPLED RECEPTOR; UNCLASSIFIED DRUG; ALPHA CHEMOKINE; CXCL17 PROTEIN, HUMAN; CXCL17 PROTEIN, MOUSE; GPR35 PROTEIN, HUMAN;

ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; GASTROINTESTINAL MUCOSA; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MOLECULAR DYNAMICS; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CYTOLOGY; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; MACROPHAGE; METABOLISM; MOLECULAR GENETICS; MONOCYTE; MOUSE; MUCOSA; NEUTROPHIL CHEMOTAXIS; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CHEMOKINES; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; HUMANS; LUNG; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MONOCYTES; MUCOUS MEMBRANE; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, G-PROTEIN-COUPLED; SEQUENCE ALIGNMENT; TRANSFECTION;

EID: 84919667247     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401704     Document Type: Article

References (34)

1. Campbell, J. J., and E. C. Butcher. 2000. Chemokines in tissue-specific and microenvironment- specific lymphocyte homing. Curr. Opin. Immunol. 12: 336-341.
2. Zlotnik, A., and O. Yoshie. 2012. The chemokine superfamily revisited. Immunity 36: 705-716.
3. Vassilatis, D. K., J. G. Hohmann, H. Zeng, F. Li, J. E. Ranchalis, M. T. Mortrud, A. Brown, S. S. Rodriguez, J. R. Weller, A. C. Wright, et al. 2003. The G proteincoupled receptor repertoires of human and mouse. Proc. Natl. Acad. Sci. USA 100: 4903-4908.
4. Pisabarro, M. T., B. Leung, M. Kwong, R. Corpuz, G. D. Frantz, N. Chiang, R. Vandlen, L. J. Diehl, N. Skelton, H. S. Kim, et al. 2006. Cutting edge: Novel human dendritic cell- and monocyte-Attracting chemokine-like protein identified by fold recognition methods. J. Immunol. 176: 2069-2073.
5. Burkhardt, A. M., K. P. Tai, J. P. Flores-Guiterrez, N. Vilches-Cisneros, K. Kamdar, O. Barbosa-Quintana, R. Valle-Rios, P. A. Hevezi, J. Zuniga, M. Selman, et al. 2012. CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity. J. Immunol. 188: 6399-6406.
6. Lee, W. Y., C. J. Wang, T. Y. Lin, C. L. Hsiao, and C. W. Luo. 2013. CXCL17, an orphan chemokine, acts as a novel angiogenic and anti-inflammatory factor. Am. J. Physiol. Endocrinol. Metab. 304: E32-E40.
7. Burkhardt, A. M., J. L. Maravillas-Montero, C. D. Carnevale, N. Vilches-Cisneros, J. P. Flores, P. A. Hevezi, and A. Zlotnik. 2014. CXCL17 is a major chemotactic factor for lung macrophages. J. Immunol. 193: 1468-1474.
8. Milligan, G. 2011. Orthologue selectivity and ligand bias: Translating the pharmacology of GPR35. Trends Pharmacol. Sci. 32: 317-325.
9. Mackenzie, A. E., J. E. Lappin, D. L. Taylor, S. A. Nicklin, and G. Milligan. 2011. GPR35 as a Novel Therapeutic Target. Front. Endocrinol. (Lausanne) 2: 68.
10. Roth, R. B., P. Hevezi, J. Lee, D. Willhite, S. M. Lechner, A. C. Foster, and A. Zlotnik. 2006. Gene expression analyses reveal molecular relationships among 20 regions of the human CNS. Neurogenetics 7: 67-80.
11. Proudfoot, A. E., C. A. Power, D. J. Church, D. Soler, and M. Mack. 2001. Cellular assays of chemokine receptor activation. Curr. Protoc. Pharmacol. Chapter 12: Unit 12.4.
12. Maravillas-Montero, J. L., P. G. Gillespie, G. Patino-López, S. Shaw, and L. Santos- Argumedo. 2011. Myosin 1c participates in B cell cytoskeleton rearrangements, is recruited to the immunologic synapse, and contributes to antigen presentation. J. Immunol. 187: 3053-3063.
13. Tang, T., L. Li, J. Tang, Y. Li, W. Y. Lin, F. Martin, D. Grant, M. Solloway, L. Parker, W. Ye, et al. 2010. A mouse knockout library for secreted and transmembrane proteins. Nat. Biotechnol. 28: 749-755.
14. Weinstein, E. J., R. Head, D. W. Griggs, D. Sun, R. J. Evans, M. L. Swearingen, M. M. Westlin, and R. Mazzarella. 2006. VCC-1, a novel chemokine, promotes tumor growth. Biochem. Biophys. Res. Commun. 350: 74-81.
15. Mu, X., Y. Chen, S. Wang, X. Huang, H. Pan, and M. Li. 2009. Overexpression of VCC-1 gene in human hepatocellular carcinoma cells promotes cell proliferation and invasion. Acta Biochim. Biophys. Sin. (Shanghai) 41: 631-637.
16. Conti, I., and B. J. Rollins. 2004. CCL2 (monocyte chemoattractant protein-1) and cancer. Semin. Cancer Biol. 14: 149-154.
17. Kurth, I., K. Willimann, P. Schaerli, T. Hunziker, I. Clark-Lewis, and B. Moser. 2001. Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J. Exp. Med. 194: 855-861.
18. Murphy, P. M. 1996. Chemokine receptors: Structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev. 7: 47-64.
19. Wang, W., H. Soto, E. R. Oldham, M. E. Buchanan, B. Homey, D. Catron, N. Jenkins, N. G. Copeland, D. J. Gilbert, N. Nguyen, et al. 2000. Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J. Biol. Chem. 275: 22313-22323.
20. Gouwy, M., S. Struyf, S. Noppen, E. Schutyser, J. Y. Springael, M. Parmentier, P. Proost, and J. Van Damme. 2008. Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events. Mol. Pharmacol. 74: 485-495.
21. Okumura, S., H. Baba, T. Kumada, K. Nanmoku, H. Nakajima, Y. Nakane, K. Hioki, and K. Ikenaka. 2004. Cloning of a G-protein-coupled receptor that shows an activity to transform NIH3T3 cells and is expressed in gastric cancer cells. Cancer Sci. 95: 131-135.
22. Horikawa, Y., N. Oda, N. J. Cox, X. Li, M. Orho-Melander, M. Hara, Y. Hinokio, T. H. Lindner, H. Mashima, P. E. Schwarz, et al. 2000. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 26: 163-175.
23. Barth, M. C., N. Ahluwalia, T. J. Anderson, G. J. Hardy, S. Sinha, J. A. Alvarez- Cardona, I. E. Pruitt, E. P. Rhee, R. A. Colvin, and R. E. Gerszten. 2009. Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions. J. Biol. Chem. 284: 19189-19195.
24. Matsui, A., H. Yokoo, Y. Negishi, Y. Endo-Takahashi, N. A. Chun, I. Kadouchi, R. Suzuki, K. Maruyama, Y. Aramaki, K. Semba, et al. 2012. CXCL17 expression by tumor cells recruits CD11b+Gr1 high F4/80- cells and promotes tumor progression. PLoS ONE 7: E44080.
25. Wu, C., C. Orozco, J. Boyer, M. Leglise, J. Goodale, S. Batalov, C. L. Hodge, J. Haase, J. Janes, J. W. Huss, III, and A. I. Su. 2009. BioGPS: An extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 10: R130.
26. Daiyasu, H., W. Nemoto, and H. Toh. 2012. Evolutionary Analysis of Functional Divergence among Chemokine Receptors, Decoy Receptors, and Viral Receptors. Front. Microbiol. 3: 264.
27. Nygaard, R., T. M. Frimurer, B. Holst, M. M. Rosenkilde, and T. W. Schwartz. 2009. Ligand binding and micro-switches in 7TM receptor structures. Trends Pharmacol. Sci. 30: 249-259.
28. Govaerts, C., C. Blanpain, X. Deupi, S. Ballet, J. A. Ballesteros, S. J. Wodak, G. Vassart, L. Pardo, and M. Parmentier. 2001. The TXP motif in the second transmembrane helix of CCR5. A structural determinant of chemokine-induced activation. J. Biol. Chem. 276: 13217-13225.
29. Cancellieri, C., N. Caronni, A. Vacchini, B. Savino, E. M. Borroni, M. Locati, and R. Bonecchi. 2013. Review: Structure-function and biological properties of the atypical chemokine receptor D6. Mol. Immunol. 55: 87-93.
30. Taniguchi, Y., H. Tonai-Kachi, and K. Shinjo. 2006. Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35. FEBS Lett. 580: 5003-5008.
31. Yung, S. C., and P. M. Murphy. 2012. Antimicrobial chemokines. Front. Immunol. 3: 276.
32. Bachelerie, F., A. Ben-Baruch, A. M. Burkhardt, C. Combadiere, J. M. Farber, G. J. Graham, R. Horuk, A. H. Sparre-Ulrich, M. Locati, A. D. Luster, et al. 2013. International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol. Rev. 66: 1-79.
33. Han, D. K., S. Y. Jeong, Y. H. Kim, and B. G. Min. 1992. Surface characteristics and blood compatibility of polyurethanes grafted by perfluoroalkyl chains. J. Biomater. Sci. Polym. Ed. 3: 229-241.
34. Ellinghaus, D., T. Folseraas, K. Holm, E. Ellinghaus, E. Melum, T. Balschun, J. K. Laerdahl, A. Shiryaev, D. N. Gotthardt, T. J. Weismuller, et al. 2013. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4. Hepatology 58: 1074-1083.